[-] Show simple item record

dc.contributor.authorKirley, Kateeng
dc.contributor.authorRowland, Kateeng
dc.contributor.otherFamily Physicians Inquiries Networkeng
dc.date.issued2011-04eng
dc.description.abstractConsider dabigatran, an oral anticoagulant that does not require monitoring, for the prevention of stroke and thromboembolism in patients with atrial fibrillation. Stength of recommendation: B: Based on a single well-done randomized controlled trial (RCT).eng
dc.identifier.citationJournal of Family Practice, 60(4) 2011: 220-222.eng
dc.identifier.urihttp://hdl.handle.net/10355/10388
dc.languageEnglisheng
dc.publisherFamily Physicians Inquiries Networkeng
dc.relation.ispartofPriority Updates to Research Literature (PURLs)eng
dc.relation.ispartofcommunityUniversity of Missouri-Columbia. School of Medicine. Department of Family and Community Medicine. Family Physicians Inquiries Networkeng
dc.rightsOpenAccess.eng
dc.rights.licenseThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License.eng
dc.subjectblood thinnereng
dc.subjectthrombin inhibitoreng
dc.titleTime to try this warfarin alternative?eng
dc.typeArticleeng


Files in this item

[PDF]

This item appears in the following Collection(s)

[-] Show simple item record